Lipid Metabolism Flashcards
**VLDL
• Source
• Composition (Apoprotein, TG:Chol)
• Functional Role
*
Source:
• Made by Liver (endogenous path)
Composition:
• ApoB-100, Apo CII, Apo CIII, Apo A-V
• Carries 5:1 ratio of Triglyceride to Cholesterol
Functional Role:
• Delivers TGs and Chol. to Adipose Tissue and Muscle
**LDL
• Source
• Composition (Apoprotein, TG:Chol)
• Functional Role
*
Source:
• Breakdown Product of IDL
Composition:
• ApoB-100, Apo(a)
• LESS than 5% Triglyceride (almost solid cholesterol)
Functional Role:
• Returns Cholesterol to Liver or
• Puts more cholesterol in Peripheral Tissues (if overloaded)
**Chylomicrons
• Source
• Composition (Apoprotein, TG:Chol)
• Functional Role
*
Source:
• made of TGs and Cholesterol that is absorbed in the Proximal Jejunum (exogenous path)
Composition:
• Apo-48, ApoC (II, III), ApoA (I, II, V), Apo E (on remnants)
• has 10:1 ratio of Triglyceride to Cholesterol
Functional Role:
• Secreted into the blood from intestines and Delivers Fat to Tissues via interactions with LPL receptors
**Lp(a)
• Source
• Composition (Apoprotein, TG:Chol)
• Functional Role
*
Source:
• Liver
Composition:
• ApoB-100
• Apo(a) - Aberrent form of Thromboplastin
Functional Role:
• VERY ATHERLOGENIC
**What are the desirable levels of:
• LDL-C
• HDL-C
• Triglyceride
*
LDL:
• Less than 130
HDL:
• Men = greater than 40
• Women = greater than 50
Triglycerides:
• Less than 120
**Typically want TOTAL CHOLESTEROL under 200
**Primary Chylomicronemia
- Inheritance
- Lipoprotein Abnormality
- Pathophysiology
- Clinical Characteristics
- Complications
*
Inheritance:
• Recessive
Lipoprotein Abnormality:
• ApoCII or LPL defect
Pathophysiology:
• ApoCII binds LPL to release TGs into tissues
• Disruption in this interaction means TGs build up in the blood
Clinical Characteristics:
• Usually found in Kids
• CHYLOMICRONS and VLDL elevated (in the 10,000 range)
Complications:
• PANCREATITIS
• Patients may get Xanthomas on chest and back
**Familial Hypertriglyceridemia
- Lipoprotein Abnormality
- Pathophysiology
- Clinical Characteristics
- Complications
*
Lipoprotein Abnormality:
• none, this is a defect in LPL
Pathophysiology:
• LPL is needed to take TGs out of VLDL
• If its absent the VLDL and TGs inside it just build up
Clinical Characteristics:
• Adults with TGs in the 1000s
• AND have elevated VLDL
Clinical Complications:
• Pancreatitis
• Often seen in diabetics
**Familial Dysbetalipoproteinemia
- Lipoprotein Abnormality
- Pathophysiology
- Clinical Characteristics
- Complications
*
Lipoprotein Abnormality:
• ApoE defect (E2/E2 alleles)
Pathophyiology:
• ApoE is used by Chylomicron remnants, IDL, and HDL to bind to the LDL receptor
• MOST IMPORTANTLY IDL never gets converted to LDL
Clinical Characteristics:
• VLDL and Chylomicron remnants High
• ELEVATED CHOLESTEROL AND TG in 1:1 ratio (~250-300)
**Familial Combined Hyperlipidemia (FCH)
- Inheritance
- Lipoprotein Abnormality
- Pathophysiology
- Clinical Characteristics
- Complications
*
Inheritance:
• Autosomal Dominant
Lipoprotein Abnormality:
• Overproduction of apoB
Pathophysiology:
• Overproduction of ApoB-100 leads to too many VLDL particles
• Ultimately this cause high cholesterol
Clinical Characteristics:
• STRONG FAMILY HISTORY of EARLY athlerosclerosis
• Variably high VLDL, LDL, or Both
Complications:
• Premature athlerosclerosis
**Familial Hypercholesterolemia (FH)
- Inheritance
- Lipoprotein Abnormality
- Pathophysiology
- Clinical Characteristics
- Complications
*
Inheritance:
• Autosomal Dominant
Lipoprotein Abnormality:
• LDL Receptor or ApoB defect
Pathophysiology:
• Decreased Receptor Mediated Removal of LDL from plasma
Clinical Characteristics:
• Young, skinny people with unusually high LDL
• LDL 400-600
Complications:
• Homozygotes = Artherlosclerosis by age 12
**Secondary Causes of Hyperlipoproteinemia
* • HypOthyroidism • Kidney or Liver Disease • Medications • Excess Calories and Simple Sugars • Genetic Factors
**What is the functional Role of:
• LDL-receptor
*
• LDL receptor binds ApoB-48 and pulls out Cholesterol
**What is the functional Role of:
• Apolipoproteins
*
• In general these mediate binding events with receptors that cause depletion of cholesterol or TG from Lipoproteins and Chylomicrons
**What is the functional Role of:
• CETP
*
Cholesteryl ester transfer protein - transfers cholesterol and TGs between (V)LDL particles and HDL
• Makes HDL larger and more susceptible to uptake by the liver via SRB1 receptor
**What is the functional Role of:
• ApoCII
*
• Found on Chylomicrons, VLDL, and HDL
• Co-factor for LPL - so it needed to drop TGs off in tissues
**What is the functional Role of:
• ApoCIII
*
• Found on Chylomicrons, VLDL, and HDL
• INHIBITS lipoprotein binding to receptors
**What is the functional Role of:
• ApoB
*
• Either ApoB-48 (chylomicrons) or Apo-100 (everything else) are the structural protein for all fat carrying particles
• LIGAND FOR BINDING LDL receptor
**What is the functional Role of:
• PPAR-a
*
• Activates Genes such as Apo CII and deactivates genes such as Apo CIII allowing for REDUCTION IN SERUM TGs